Recent recommendations on psoriatic arthritis treatment in accordance with 2018 American College of Rheumatology and National Psoriasis Foundation guidelines
Journal Title: Біль. Суглоби. Хребет - Year 2019, Vol 9, Issue 1
Abstract
Psoriatic arthritis (PsA) is a chronic inflammatory skeletal and muscular disease associated with psoriasis, which usually manifests itself in the peripheral arthritis, dactylitis, enthesitis and/or spondylitis. Early identification and diagnosis of PsA, as well as early start of therapy is important for improving the long-term outcomes of the disease. Clinical picture of PsA is heterogeneous, and doctors often face problems while determining treatment strategies. The purpose of our review was to discuss and interpret 2018 American College of Rheumatologists (ACR) and National Psoriasis Foundation (NPF) guidelines for active PSA treatment in adults using pharmacological and non-pharmacological methods. These recommendations may help both clinicians and patients to make their best decisions about disease management. The presence or absence of comorbid conditions such as inflammatory bowel disease, uveitis, diabetes or serious infections, as well as knowledge of medical history are factors enabling choice of an optimal therapy for a particular patient at a given time using a customized treatment approach. ACR/NPF guidelines for active PsA treatment recommend tumor necrosis factor inhibitors rather than small molecule oral drugs as a first line therapy, precisely because these biological agents prevent progression of the disease and joint damage. Early and aggressive therapy is emphasized in patients with a newly diagnosed PsA.
Authors and Affiliations
I. Yu. Golovach, Ye. D. Yehudina
Keywords
Related Articles
- EP ID EP582119
- DOI 10.22141/2224-1507.9.1.2019.163058
- Views 51
- Downloads 0
Pharmacological Correction of Remodeling Disprders in Delayed Union of Pertrochanteric Fracture of the Femur on the Background of Systemic Osteoporosis
.
Dysmobility syndrome: a paradigm shift in fracture prevention
Fragility fractures engender major healthcare cost, reduce independence/quality and life and increase mortality risk. Despite availability of multiple therapies to reduce risk for future fracture, few patients are treate...
Features of bone metabolism in patients with osteoarthritis, type 2 diabetes mellitus and their combination
Background. Osteoarthritis (OA) is one of the most common joint diseases characterized by periodic exacerbations, pain syndrome of varying severity, progressive course, which leads to deformity of the joints, a decrease...
Copper and Zinc Content in the Organism of Patients with Rheumatoid and Psoriatic Arthritis
In rheumatoid and psoriatic arthritis, Cu-Zn-microelementosis develops, which is involved in the pathogenesis of diseases. Concentration of these microelements in the blood has an impact on the prevalence, stage and seve...
Clinical and Pathogenetic Significance of Osteoassociated Microelements in the Joint Diseases. Report II: Microelementosis in the Hair
The relevance. Microelementosis (imbalance of certain microelements in the body, ME) is considered as one of the most important clinical and pathogenetic components of degenerative and inflammatory joint diseases. ME can...